| |
| |
|
| Insider
Information: |
Middleton Fred A |
| Relationship: |
|
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
593,164 |
|
|
Indirect Shares
|
7,544,680 |
|
|
| Direct
Value |
$3,059,061 |
|
|
|
Indirect Value
|
$6,091,574 |
|
|
| Total
Shares |
8,137,844 |
|
|
| Total
Value |
$9,150,635 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 2.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stereotaxis Inc |
STXS |
Director |
2018-03-02 |
303,528 |
2018-03-02 |
1,325,167 |
Premium* |
|
|
Mmrglobal Inc |
MMRF |
Director |
2008-12-09 |
0 |
2006-03-07 |
2,773,091 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-24 |
70,399 |
2013-06-24 |
0 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2023-11-17 |
207,523 |
2023-11-17 |
3,407,954 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
|
2024-01-23 |
11,714 |
2024-01-23 |
38,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-19 |
4 |
AS |
$29.76 |
$1,440,384 |
I/I |
(48,400) |
96,898 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-18 |
4 |
AS |
$29.48 |
$872,608 |
I/I |
(29,600) |
145,298 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-20 |
4 |
AS |
$28.93 |
$1,912,273 |
I/I |
(66,100) |
30,798 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-24 |
4 |
AS |
$28.70 |
$169,330 |
I/I |
(5,900) |
0 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-06-21 |
4 |
AS |
$28.49 |
$2,041,714 |
I/I |
(70,000) |
5,900 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-03-18 |
4 |
AS |
$28.19 |
$4,745,234 |
D/D |
(165,411) |
0 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-03-11 |
4/A |
S |
$27.86 |
$9,721,775 |
D/D |
(348,951) |
559,453 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-03-19 |
4 |
AS |
$26.95 |
$2,306,831 |
D/D |
(84,589) |
416,083 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-03-07 |
4/A |
S |
$25.92 |
$662,515 |
D/D |
(25,560) |
1,361,762 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-12-21 |
4 |
D |
$24.00 |
$2,723,736 |
D/D |
(113,489) |
0 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-12-21 |
4 |
D |
$24.00 |
$97,094,808 |
I/I |
(4,045,617) |
0 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-01-24 |
4/A |
S |
$18.93 |
$9,465,000 |
D/D |
(500,000) |
882,562 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2007-06-21 |
4 |
S |
$12.04 |
$1,469 |
I/I |
(122) |
0 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2006-09-27 |
4 |
D |
$10.49 |
$3,755 |
I/I |
(358) |
122 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2013-08-07 |
4 |
S |
$10.13 |
$800,007 |
I/I |
(78,974) |
5,335 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2013-08-07 |
4/A |
D |
$10.13 |
$800,007 |
I/I |
(78,974) |
5,335 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2004-08-27 |
4 |
B |
$7.90 |
$17,159 |
I/I |
2,172 |
8,172 |
2.1 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2021-06-28 |
4 |
B |
$7.83 |
$54,419 |
D/D |
6,950 |
207,523 |
2.39 |
% |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2005-05-17 |
4 |
B |
$7.79 |
$7,790 |
D/D |
1,000 |
141,947 |
2.39 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2021-06-25 |
4 |
B |
$7.78 |
$23,729 |
D/D |
3,050 |
200,573 |
2.39 |
% |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2004-08-13 |
4 |
B |
$7.65 |
$38,230 |
I/I |
5,000 |
5,000 |
2.1 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2004-08-17 |
4 |
B |
$7.61 |
$7,610 |
I/I |
1,000 |
6,000 |
2.1 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2005-06-08 |
4 |
B |
$7.10 |
$41,910 |
D/D |
5,828 |
147,775 |
2.39 |
- |
|
| MMRF |
Mmrglobal Inc |
Director |
– • • |
2005-02-07 |
4 |
B |
$7.00 |
$7,999,999 |
I/I |
1,142,857 |
3,182,652 |
2.25 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2011-02-08 |
4 |
B |
$7.00 |
$1,874,999 |
I/I |
267,857 |
184,131 |
2.1 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
